{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T11:25:04Z","timestamp":1760441104814},"reference-count":31,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":11534,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1981,8,9]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Vomiting accompanied by nausea is a serious acute toxicity which occurs after chemotherapy with virtually every class of cancer chemotherapeutic agents. The inability to adequately alleviate this toxicity may lead to serious complications such as general malaise, weight loss, and electrolyte imbalance. We have reviewed 34 studies in which more than 2200 cancer patients were administered 25 different antiemetics for treatment of chemotherapy\u2010induced vomiting. All patients received a variety of cancer chemotherapeutic agents given either as single agents or in combination. The antiemetic agents included phenothiazines, antihistamines, anticholinergics, benzoquinolizines, barbiturates, butyrophenones, procainamides, cannabinoids, steroids, and benzodiazepines. It is apparent from these studies that the use of conventional antiemetic agents for treating cancer chemotherapy\u2010induced vomiting is of marginal value, and the use of investigational antiemetic agents show conflicting results as to efficacy. More quantitative measures for evaluating emesis need to be defined, and the implications that a particular antiemetic therapy may be efficacious for some but not all classes of cancer chemotherapeutic agents need to be evaluated.<\/jats:p>","DOI":"10.1002\/j.1552-4604.1981.tb02568.x","type":"journal-article","created":{"date-parts":[[2013,3,9]],"date-time":"2013-03-09T01:35:12Z","timestamp":1362792912000},"source":"Crossref","is-referenced-by-count":21,"title":["Clinical Trials with Antiemetic Agents in Cancer Patients Receiving Chemotherapy"],"prefix":"10.1002","volume":"21","author":[{"given":"JOHN S.","family":"PENTA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DON S.","family":"POSTER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SALVADOR","family":"BRUNO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOHN S.","family":"MACDONALD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197507242930416"},{"key":"e_1_2_1_3_2","first-page":"1106","article-title":"A single dose of metoclopramide in the control of vomiting from cis\u2010dichlorodiammineplatinum(II) in man","volume":"62","author":"Kahn T","year":"1978","journal-title":"Cancer Treat Rep."},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1963.03710020036011"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(19)33898-3"},{"key":"e_1_2_1_6_2","first-page":"283","article-title":"Controlled studies of metopimazine for the treat ment of nausea and vomiting","volume":"13","author":"Moertel CG","year":"1973","journal-title":"J Clin Pharmacol."},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/cpt1975185part1554","article-title":"Oral benzquinamide in the treatment of nausea and vomiting","volume":"18","author":"Moertel CG","year":"1976","journal-title":"Clin Pharmacol Therap."},{"key":"e_1_2_1_8_2","first-page":"255","article-title":"Emetic and antiemetic drugs","volume":"11","author":"Wang SC III","year":"1965","journal-title":"Physiol Pharmacol."},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/009127008002000508"},{"key":"e_1_2_1_10_2","first-page":"344","article-title":"Metoclopramide(MCP) vs. prochlorperazine (PCP) in the prevention of vomiting from diamminedichloroplatinum (DDP)","volume":"21","author":"Arnold DJ","year":"1980","journal-title":"Proc AACR ASCO."},{"key":"e_1_2_1_11_2","first-page":"350","article-title":"Phase I intravenous trial of the antiemetic metoclopramide in patients receiving cis\u2010platinum (DDP)","volume":"21","author":"Gralla RJ","year":"1980","journal-title":"Proc AACR ASCO"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6199.1188"},{"key":"e_1_2_1_13_2","first-page":"331","article-title":"Nabilone: a potent antiemetic cannabinol with minimal euphoria","volume":"27","author":"Herman TS","year":"1977","journal-title":"Biomedicine."},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197806292982616"},{"key":"e_1_2_1_15_2","first-page":"30","article-title":"Nabilone (N) anti\u2010emetic crossover study in cancer chemotherapy patients","volume":"19","author":"Nagy CM","year":"1978","journal-title":"Proc AACR ASCO"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197906073002302"},{"key":"e_1_2_1_17_2","article-title":"The status of delta\u20109\u2010tetrahydrocannabinol in clinical oncology","author":"Poster DS","journal-title":"JAMA."},{"key":"e_1_2_1_18_2","first-page":"203","article-title":"Two\u2010pronged study of tetrahydrocannabinol (THC) prevention of vomiting from cancer chemotherapy","volume":"8","author":"Garb S","year":"1980","journal-title":"IRCS Med Sci."},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197510162931603"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-91-6-819"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-91-6-825"},{"key":"e_1_2_1_22_2","first-page":"338","article-title":"Delta\u20109\u2010tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancer chemotherapy; a double\u2010blind cross\u2010over trial against placebo","volume":"21","author":"Kluin\u2010Neleman JC","year":"1979","journal-title":"Vet Human Toxicol."},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1979.tb127271.x"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198001173020302"},{"key":"e_1_2_1_25_2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jama.1980.03300380021014","article-title":"\u03949\u2010Tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy","volume":"243","author":"Lucas VS","year":"1980","journal-title":"JAMA"},{"key":"e_1_2_1_26_2","article-title":"Antiemetic effect of delta\u20109\u2010tetrahydrocannabinol in chemotherapy\u2010associated nausea and emesis as compared to placebo and compazine","author":"Orr LE","journal-title":"Arch Int Med."},{"key":"e_1_2_1_27_2","first-page":"599","article-title":"Haloperidol in the treatment of nausea and vomiting due to cytotoxic drug administration","volume":"15","author":"Plotkin DA","year":"1973","journal-title":"Curr Therap Res."},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950070309"},{"key":"e_1_2_1_29_2","article-title":"Pronounced antiemetic activity of the antipsychotic drug levomepromacine (L) in patients receiving cancer chemotherapy","author":"Higi M","journal-title":"Arzneim-Forschung."},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198006123022414"},{"key":"e_1_2_1_31_2","first-page":"1364","article-title":"Delta\u20109\u2010tetrahydrocannabinol (THC) as an antiemetic","volume":"302","author":"Zeltzer L","year":"1980","journal-title":"N Engl J Med."},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.2307\/3424683"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1552-4604.1981.tb02568.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1552-4604.1981.tb02568.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T05:50:08Z","timestamp":1694584208000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/j.1552-4604.1981.tb02568.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,8,9]]},"references-count":31,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1981,8,9]]}},"alternative-id":["10.1002\/j.1552-4604.1981.tb02568.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1552-4604.1981.tb02568.x","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,8,9]]}}}